假性剥脱的12年发病率及基线危险因素:塞萨洛尼基眼研究(美国眼科学会论文)
该研究为希腊北部塞萨洛尼基的纵向人群研究,基线2554名≥60岁白人,12年后1092人参与随访。假性剥脱12年发病率为19.6%(95%CI 17.1-22.2),女性更易受累;在基线有假性剥脱者中,基线眼压较高和基线心脏病发作史与发生假性剥脱性青光眼可能性更大相关,基线饮酒史具保护作用。
要点
- 假性剥脱12年发病率为19.6%(95%CI 17.1-22.2),女性较男性更易受累(Fisher精确检验P=.0197)。
- 眼轴较长与发生假性剥脱的比值比较低相关(每毫米OR 0.72;95%CI 0.57-0.92)。
- 基线有假性剥脱者中,基线眼压较高(每mm Hg OR 1.26;95%CI 1.07-1.48)和基线心脏病发作史(OR 13.49;95%CI 2.85-63.87)与发生假性剥脱性青光眼可能性更大相关。
核心结论
- 在基线有假性剥脱的个体中,基线眼压较高、基线心脏病发作史和无饮酒与约12年后发生青光眼性损害可能性更大相关。
- 基线假性剥脱与主要血管疾病可能性增加不相关(P=.9038)。
- 与眼轴的关联此前仅见于横断面研究,与心脏病发作和饮酒的关联为新发现。
研究设计与样本
- 纵向人群研究,地点为希腊北部主要城市中心塞萨洛尼基。
- 基线队列包括2554名≥60岁参与者,存活队列12年后以相同方法重新检查。
- 存活队列1468名合格受试者中1092名(74%)参与随访研究,基线平均年龄±标准差为68.9±4.6岁,平均随访时间11.6±1.6年。
- 假性剥脱定义为瞳孔缘和/或晶状体囊膜上的典型纤维状物质;青光眼定义为结构和功能损害,不论眼压如何。
主要发现
- 假性剥脱12年发病率为19.6%(95%CI 17.1-22.2),女性较男性更易受累(Fisher精确检验P=.0197)。
- 眼轴较长与发生假性剥脱的比值比较低相关(每毫米OR 0.72;95%CI 0.57-0.92)。
- 基线假性剥脱与主要血管疾病可能性增加不相关(P=.9038)。
- 基线眼压较高与基线有假性剥脱者发生假性剥脱性青光眼可能性更大相关(每mm Hg OR 1.26;95%CI 1.07-1.48)。
- 基线心脏病发作史与基线有假性剥脱者发生假性剥脱性青光眼可能性更大相关(OR 13.49;95%CI 2.85-63.87)。
关键数值与推荐
- 假性剥脱12年发病率为19.6%(95%CI 17.1-22.2)。
- 眼轴每增加1 mm,发生假性剥脱的OR为0.72(95%CI 0.57-0.92)。
- 基线眼压每增加1 mm Hg,基线有假性剥脱者发生假性剥脱性青光眼的OR为1.26(95%CI 1.07-1.48)。
- 基线有心脏病发作史者发生假性剥脱性青光眼的OR为13.49(95%CI 2.85-63.87)。
- 基线有假性剥脱者中,基线饮酒史对发生假性剥脱性青光眼具保护作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the 12-year incidence of pseudoexfoliation (PEX), baseline risk factors for incident PEX and risk factors for incident pseudoexfoliative glaucoma (PEXG) among those with PEX in an elderly white population. METHODS: Longitudinal, population-based study in Thessaloniki, the major urban center in Northern Greece. The baseline cohort included 2554 participants ≥60 years old. The surviving cohort was re-examined 12 years later using the same methodology. PEX was defined as typical fibrillar material at the pupil margin and/or on the lens capsule. Glaucoma was defined as both structural and functional damage, irrespective of intraocular pressure (IOP). RESULTS: Of 1468 eligible subjects in the surviving cohort, 1092 (74%) participated in the follow-up study. The mean age ± standard deviation (SD) at baseline was 68.9 ± 4.6 years. The mean follow-up time was 11.6 ± 1.6 years. The 12-year incidence of PEX was 19.6% (95% confidence interval (CI), 17.1-22.2), with women more likely to be affected than men (Fisher's exact test, P = .0197). Higher axial length was associated with lower odds of incident PEX (odds ratio [OR], 0.72 per mm; 95% CI, 0.57-0.92). PEX at baseline was not associated with an increased likelihood of major vascular disease (P = .9038). Higher baseline IOP (OR, 1.26 per mm Hg; 95% CI, 1.07-1.48) and history of heart attack at baseline (OR, 13.49; 95% CI, 2.85-63.87) were associated with a greater likelihood of developing PEXG among those with PEX. A history of alcohol consumption at baseline was protective of individuals developing PEXG if they had PEX at baseline. CONCLUSION: This is one of the very few longitudinal population-based studies that has specifically assessed the incidence of PEX. The association with axial length was previously found only in a cross-sectional study. The associations with heart attack and alcohol consumption are new findings. In individuals with baseline PEX, higher IOP at baseline, history of heart attack at baseline, and no alcohol consumption were associated with a greater likelihood of developing glaucomatous damage approximately 12 years later. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
引用
- Topouzis F, Founti P, Yu F, et al. Twelve-Year Incidence and Baseline Risk Factors for Pseudoexfoliation: The Thessaloniki Eye Study (An American Ophthalmological Society Thesis). Am J Ophthalmol. 2019. PMID: 31095955. doi:10.1016/j.ajo.2019.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。